logo

For the Inventor, By the Inventor

Montclair, NJ, United States of America

Arthur R Mlodozeniec

This inventor holds 9 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1977-1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur R Mlodozeniec. Retrieved from https://idiyas.com/inventor/arthur-r-mlodozeniec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 8

Forward Citations = 429(Granted Patents)


Company Filing History:

goldMedal9 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents

Years Active: 1977-1982

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4349531 - Novel dosage form (1982-09-14),
2. 4332789 - Pharmaceutical unit dosage forms (1982-06-01),
3. 4307555 - System for producing dosage forms (1981-12-29),
4. 4197289 - Novel dosage forms (1980-04-08),
5. 4128445 - Manufacture of pharmaceutical unit dosage forms (1978-12-05),
6. 4128444 - Manufacture of pharmaceutical unit dosage forms (1978-12-05),
7. 4069084 - Novel dosage form (1978-01-17),
8. 4029758 - Preparation of pharmaceutical unit dosage forms (1977-06-14),
9. 4029757 - Manufacture of pharmaceutical unit dosage forms (1977-06-14),

Title: Arthur R. Mlodozeniec: Innovator in Pharmaceutical Dosage Forms

Introduction

Arthur R. Mlodozeniec is a notable inventor based in Montclair, NJ (US), recognized for his contributions to the field of pharmaceutical dosage forms. He holds a total of 9 patents, showcasing his innovative approach to medication delivery systems.

Latest Patents

Among his latest patents, Mlodozeniec has developed novel dosage forms that comprise an edible web with a particulate medicament deposited thereon. These dosage forms are fabricated to ensure that no medicament is exposed on the exterior surface, allowing for a controlled release of the medicament to exacting specifications. The manufacturing process utilizes high-speed automated equipment, characterized by non-destructive quality control analysis and performance evaluation conducted online. This innovative approach also includes certain apparatus and methods of manufacture that enhance the efficiency and effectiveness of pharmaceutical production.

Career Highlights

Arthur R. Mlodozeniec is currently associated with Hoffmann-La Roche Inc., where he continues to advance the field of pharmaceutical sciences. His work has significantly impacted the way medications are formulated and delivered, ensuring that patients receive effective treatments in a reliable manner.

Collaborations

Throughout his career, Mlodozeniec has collaborated with esteemed colleagues, including Arthur H. Goldberg and August Sturzenegger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.

Conclusion

Arthur R. Mlodozeniec's contributions to pharmaceutical dosage forms exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving medication delivery systems, ultimately benefiting patients and the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…